These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2495588)

  • 21. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
    Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
    Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolerance induction with anti-CD8 monoclonal antibodies in the mouse heart transplant model.
    Mottram PL; Purcell LJ; Pietersz GA; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2935-6. PubMed ID: 8212289
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac allograft prolongation in mice treated with combined posttransplantation total-lymphoid irradiation and anti-L3T4 antibody therapy.
    Trager DK; Banks BA; Rosenbaum GE; Holm BI; Shizuru JA; Strober S; Fathman CG
    Transplantation; 1989 Apr; 47(4):587-91. PubMed ID: 2523098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
    Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
    Duguid IG; Koulmanda M; Mandel TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts.
    Madsen JC; Peugh WN; Wood KJ; Morris PJ
    Transplantation; 1987 Dec; 44(6):849-52. PubMed ID: 3321596
    [No Abstract]   [Full Text] [Related]  

  • 29. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
    Lowry RP; Konieczny B; Alexander D; Larsen C; Pearson T; Smith S; Narula S
    Transplant Proc; 1995 Feb; 27(1):392-4. PubMed ID: 7879034
    [No Abstract]   [Full Text] [Related]  

  • 30. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model.
    Han WR; Mottram PL; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2933-4. PubMed ID: 8105591
    [No Abstract]   [Full Text] [Related]  

  • 32. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H; Hara MH; Miyahara T; Tanigawa M; Matsuzaki Y; Onitsuka T; Shibata K; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Iwaya M; Miyasaka M; Kimura H
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of myosin-induced autoimmune myocarditis in mice by anti-L3T4 monoclonal antibody.
    Yuan HT; Liao YH; Wang Z; Dong JH; Cao LS; Wang ZH; Wang JP; Fu ML
    Can J Physiol Pharmacol; 2003 Feb; 81(2):84-8. PubMed ID: 12710519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
    Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
    Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.
    Qin L; Chavin KD; Lin J; Yagita H; Bromberg JS
    J Exp Med; 1994 Jan; 179(1):341-6. PubMed ID: 7903681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies.
    Rebellato L; Gross U; Carver M; Cunningham P; Riley R; Ross W; Knowles R; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):598-9. PubMed ID: 8094911
    [No Abstract]   [Full Text] [Related]  

  • 40. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M; Ihara A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.